- Latest news▼
-
15:32, April 26 ESCMID: New method of purifying the air with ultraviolet light could protect world from new pandemic
-
08:43, April 26 Enzymes that convert different blood groups into first group are discovered
-
19:41, April 25 Children’s Hospital Los Angeles and International Center of Professional Development Allergy/Immunology Conference
-
17:31, April 25 JAMA: patient grew long, curly eyelashes because of chemotherapy
-
11:08, April 25 Mpox epidemic declared in Republic of the Congo
-
08:31, April 25 OU: quitting smoking 4 times more likely to cure laryngeal cancer
-
01:20, April 25 Paralyzed man in China writes hieroglyphs using neural implants placed in his brain
-
15:11, April 24 Zombie deer disease possibly linked to hunters’ deaths
-
12:27, April 23 Appetite: Scientists found out the secret to the appeal of large portions of fast food
-
10:33, April 23 Scientists test new approach to fighting viruses
-
08:38, April 23 Ketamine may help with postpartum depression
-
22:12, April 22 Unhealthy amount of sugar found in baby food products of a well-known brand
-
19:41, April 22 Air pollution puts health of more than 1.6 billion workers globally at risk
-
17:25, April 22 Scientists found baked goods and lack of sleep to be more dangerous than alcohol
-
16:02, April 22 342 cases of measles recorded in Armenia so far in 2024
All materials
Vaccine against Omicron variant expected to be available in March 2022
December 9, 2021 09:47
BioNTech SE and Pfizer Inc. are working together on an effective vaccine against the Omicron variant of the coronavirus. These companies promise to present the finished product by March next year.
According to a press release on the website of the American pharmaceutical company, the serum antibodies produced by the Pfizer-BioNTech vaccine will neutralize this new variant of COVID-19 after three doses. And in the case of two doses, the neutralizing antibodies’ activeness against Omicron is 25 times lower.
Additional research by these companies shows that the current booster shots of Pfizer and BioNTech increase antibody titers by 25 times.
Follow NEWS.am Medicine on Facebook and Twitter
- Video
- Event calendar
- Children’s Hospital Los Angeles and International Center of Professional Development Allergy/Immunology Conference
- First Armenian-German Conference entitled “Heart Failure Spring School”
- Allogeneic bone marrow transplant in case of hematological malignancy performed in Armenia for first time
All materials
- Archive
- Most read
month
week
day
- Scientists found baked goods and lack of sleep to be more dangerous than alcohol 1062
- 342 cases of measles recorded in Armenia so far in 2024 980
- Unhealthy amount of sugar found in baby food products of a well-known brand 958
- Air pollution puts health of more than 1.6 billion workers globally at risk 948
- Ketamine may help with postpartum depression 938
- Appetite: Scientists found out the secret to the appeal of large portions of fast food 933
- Scientists test new approach to fighting viruses 912
- Zombie deer disease possibly linked to hunters’ deaths 883
- Scientists develop new method to safely stimulate immune cells to fight cancer 844
- Cognitively stimulating jobs in midlife could lower dementia risk in old age, study finds 839
- Blood test can determine who is at risk of developing multiple sclerosis - scientists 838
- BrainStimulation: electrical brain stimulation alleviates anxiety and depression in the elderly 773
- Mpox epidemic declared in Republic of the Congo 675
- Paralyzed man in China writes hieroglyphs using neural implants placed in his brain 659
- Children’s Hospital Los Angeles and International Center of Professional Development Allergy/Immunology Conference 582
- Find us on Facebook
- Poll
How much money from your income are you willing to allocate monthly on health insurance?